Page last updated: 2024-10-25

clofazimine and Lung Neoplasms

clofazimine has been researched along with Lung Neoplasms in 6 studies

Clofazimine: A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
clofazimine : 3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Clofazimine was shown to have a direct cytotoxic effect in vitro with an ID50 of 10."1.29Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo. ( Fearon, KC; Plumb, JA; Sri-Pathmanathan, RM, 1994)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Parvathaneni, V1
Chilamakuri, R1
Kulkarni, NS1
Wang, X1
Agarwal, S1
Gupta, V1
Van Rensburg, CE3
Anderson, R2
Myer, MS1
Jooné, GK1
O'Sullivan, JF1
Sri-Pathmanathan, RM1
Plumb, JA1
Fearon, KC1
Jooné, G1
Durandt, C1
Wilkie, D1

Other Studies

6 other studies available for clofazimine and Lung Neoplasms

ArticleYear
Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
    Life sciences, 2022, Oct-01, Volume: 306

    Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Clofazimine; D

2022
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line.
    Cancer letters, 1994, Sep-30, Volume: 85, Issue:1

    Topics: Anti-Infective Agents; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Small Cell; Cell Divi

1994
Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo.
    International journal of cancer, 1994, Mar-15, Volume: 56, Issue:6

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Divisio

1994
Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669.
    Cancer letters, 1998, May-15, Volume: 127, Issue:1-2

    Topics: Acridines; Cell Death; Clofazimine; Cyclosporine; Drug Resistance, Multiple; Humans; Isoquinolines;

1998
Effects of tetramethylpiperidine (TMP)-substituted phenazines on membrane stability and P-glycoprotein function.
    International journal of oncology, 2001, Volume: 19, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzothiazoles; Carcinoma, Small Cell; Cell

2001
Antimitochondrial drugs in cancer chemotherapy: preliminary communication.
    Journal of the Royal Society of Medicine, 1979, Volume: 72, Issue:8

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Clofazimine; Clomipramine; Cricetinae; Lung Neoplas

1979